The TAPUR study focuses on advanced cancer patients. Researchers are testing drugs that are approved by the Food and Drug Administration (FDA) to see if they work on tumors with special gene changes. These gene changes make some cancers sensitive to certain medications. The study is *non-randomized*, meaning patients receive specific treatments based on their tumor's genetic profile, not by chance.
Key Points:
- Participants need to be 12 years or older and have a specific type of cancer that no longer benefits from standard treatment.
- Patients must have a genetic test showing they might benefit from one of the study drugs.
- Participants will need to agree to regular doctor visits and follow the study guidelines.
To join, patients must have a measurable tumor and good organ function. They should be able to swallow pills, and women must use birth control. Some patients, like those with brain tumors or who can't have their cancer measured, may not be eligible. To learn more, contact your local TAPUR site or email TAPUR@asco.org.
How understandable was the trial content above?
Hard to understand
Easy to understand